← Back to headlines
Boston Scientific's SEISMIQ 4CE Succeeds in Coronary Artery Disease Trial
Boston Scientific announced that its SEISMIQ 4CE device successfully completed trials for treating coronary artery disease.
19 May, 11:47 — 19 May, 11:47
Sources
Showing 1 of 1 sources
Related Stories
Film Reviews: Celebrity-Packed Movie and Lithuanian Sci-Fi 'Dog Star'
36m ago
Salesforce and Anthropic Expand AI Partnership Amid SaaS Market Concerns
37m ago
Nvidia Posts Record Earnings as Shares Stall on Valuation Worries
40m ago
Apple Sets September 9 Event for Next iPhone Launch Amid Foldable Model Speculation
43m ago